Detection of protein biomarkers using RNA aptamer microarrays and enzymatically amplified surface plasmon resonance imaging.

A methodology for the detection of protein biomarkers at picomolar concentrations that utilizes surface plasmon resonance imaging (SPRI) measurements of RNA aptamer microarrays is developed. The adsorption of proteins onto the RNA microarray is detected by the formation of a surface aptamer-protein-antibody complex. The SPRI response signal is then amplified using a localized precipitation reaction catalyzed by the enzyme horseradish peroxidase that is conjugated to the antibody. This enzymatically amplified SPRI methodology is first characterized by the detection of human thrombin at a concentration of 500 fM; the appropriate thrombin aptamer for the sandwich assay is identified from a microarray of three potential thrombin aptamer candidates. The SPRI method is then used to detect the protein vascular endothelial growth factor (VEGF) at a biologically relevant concentration of 1 pM. VEGF is a signaling protein that has been used as a serum biomarker for rheumatoid arthritis, breast cancer, lung cancer, and colorectal cancer and is also associated with age-related macular degeneration.

[1]  Robert M. Corn,et al.  Fabrication and characterization of RNA aptamer microarrays for the study of protein–aptamer interactions with SPR imaging , 2006, Nucleic acids research.

[2]  R. Corn,et al.  Surface plasmon resonance imaging measurements of antibody arrays for the multiplexed detection of low molecular weight protein biomarkers. , 2006, Analytical chemistry.

[3]  D. Bunka,et al.  Aptamers come of age – at last , 2006, Nature Reviews Microbiology.

[4]  Q. Cheng,et al.  Surface plasmon resonance imaging analysis of protein-receptor binding in supported membrane arrays on gold substrates with calcinated silicate films. , 2006, Journal of the American Chemical Society.

[5]  W. Leung,et al.  Diagnosis of gastric cancer by serum proteomic fingerprinting. , 2006, Gastroenterology.

[6]  A. Roda,et al.  Development and validation of a sensitive and fast chemiluminescent enzyme immunoassay for the detection of genetically modified maize , 2006, Analytical and bioanalytical chemistry.

[7]  K. Hayashi,et al.  Vascular Endothelial Growth Factor Messenger RNA Expression Level Is Preserved in Liver Metastases Compared with Corresponding Primary Colorectal Cancer , 2006, Clinical Cancer Research.

[8]  P. Geurts,et al.  Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. , 2005, Arthritis and rheumatism.

[9]  R. Georgiadis,et al.  Quantitative angle-resolved SPR imaging of DNA-DNA and DNA-drug kinetics. , 2005, Journal of the American Chemical Society.

[10]  A. Ryan,et al.  Vascular-targeting agents and radiation therapy in lung cancer: where do we stand in 2005? , 2005, Clinical lung cancer.

[11]  Sung-Hwan Park,et al.  Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies , 2005, Nucleic acids research.

[12]  Hans Wolf,et al.  An aptamer-based protein biochip. , 2005, Analytical chemistry.

[13]  Eun Jeong Cho,et al.  Functional RNA microarrays for high-throughput screening of antiprotein aptamers. , 2005, Analytical biochemistry.

[14]  Min-Gon Kim,et al.  Enhanced sensitivity of surface plasmon resonance (SPR) immunoassays using a peroxidase-catalyzed precipitation reaction and its application to a protein microarray. , 2005, Journal of immunological methods.

[15]  B. Sullenger,et al.  Aptamers: an emerging class of therapeutics. , 2005, Annual review of medicine.

[16]  D. J. Harrison,et al.  Label-free reading of microarray-based immunoassays with surface plasmon resonance imaging. , 2004, Analytical chemistry.

[17]  R. Corn,et al.  Enzymatically amplified surface plasmon resonance imaging method using RNase H and RNA microarrays for the ultrasensitive detection of nucleic acids. , 2004, Analytical chemistry.

[18]  B. Shen,et al.  Screening of functional antidotes of RNA aptamers against bovine thrombin , 2004, FEBS letters.

[19]  Rachel Ostroff,et al.  Photoaptamer arrays applied to multiplexed proteomic analysis , 2004, Proteomics.

[20]  Charles T Campbell,et al.  Quantitative methods for spatially resolved adsorption/desorption measurements in real time by surface plasmon resonance microscopy. , 2004, Analytical chemistry.

[21]  Nobuko Hamaguchi,et al.  Aptamer-based biosensor arrays for detection and quantification of biological macromolecules. , 2003, Analytical biochemistry.

[22]  K. Hagihara,et al.  Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[23]  S. Olson,et al.  Binding of Exosite Ligands to Human Thrombin , 2002, The Journal of Biological Chemistry.

[24]  Frances S Ligler,et al.  Demonstration of four immunoassay formats using the array biosensor. , 2002, Analytical chemistry.

[25]  B. Sullenger,et al.  Generation of species cross-reactive aptamers using "toggle" SELEX. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  R. Huang,et al.  Detection of multiple proteins in an antibody-based protein microarray system. , 2001, Journal of immunological methods.

[27]  M. R. Jackson,et al.  Fibrin sealants in surgical practice: An overview. , 2001, American journal of surgery.

[28]  R. Corn,et al.  Surface plasmon resonance imaging measurements of DNA and RNA hybridization adsorption onto DNA microarrays. , 2001, Analytical chemistry.

[29]  R Bicknell,et al.  Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. , 2000, Cancer research.

[30]  L. Gold,et al.  Aptamers as therapeutic and diagnostic agents. , 2000, Journal of biotechnology.

[31]  S. Jayasena.  Aptamers: an emerging class of molecules that rival antibodies in diagnostics. , 1999, Clinical chemistry.

[32]  C. Gibbs,et al.  Allosteric effects of a monoclonal antibody against thrombin exosite II. , 1998, Biochemistry.

[33]  John W. Silzel,et al.  Mass-sensing, multianalyte microarray immunoassay with imaging detection. , 1998, Clinical chemistry.

[34]  M F Kubik,et al.  Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. , 1997, Journal of molecular biology.

[35]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[36]  D. Drolet,et al.  An enzyme-linked oligonucleotide assay , 1996, Nature Biotechnology.

[37]  N. Janjić,et al.  Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor. , 1994, Biochemistry.